The Toxicology of a Manufacturing Process · What EFSA's 2026 retrospective review of food-enzyme studies reveals about impurities, exposure, biological relevance and the next generation of safety dossiers
A 2026 European Food Safety Authority retrospective examination of 258 ninety-day rodent studies submitted for food-enzyme assessments offers a consequential but easily misread signal. EFSA reported that most studies revealed no safety concern and that the comparatively few observed effects were associated with local gastric phenomena of limited human relevance or manufacturing-related impurities rather than the enzyme protein itself. This article asks what such a finding can legitimately change in industrial toxicology, and what it cannot. The discussion connects microbial strain identification, fermentation control, total organic solids, dietary exposure, process-specific removal, allergenicity, non-animal methods and the legal architecture of food-enzyme authorisation. Two recent EFSA opinions provide contrasting quantitative examples. A proposed research programme would link process fingerprints and impurity profiles to exposure-informed toxicological decisions, without treating an exploratory retrospective pattern as a waiver of statutory evidence. The industrial opportunity is not to dispense with safety testing, but to build better, more discriminating evidence about where hazards originate and how they reach consumers.
Authors
- Jose Manuel López (ORCID: https://orcid.org/0009-0006-9238-0080)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-15
- DOI
- https://doi.org/10.5281/zenodo.24244867
- Primary Topic
- Agricultural safety and regulations
- Type
- article
- Field-Weighted Citation Impact
- 0.00